Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
نویسندگان
چکیده
Author details Medicine Service and Center for Surgical Medical Acute care Research and Transitions (C-SMART), Birmingham VA Medical Center, 700 South 19th Street, Birmingham 35233, AL, USA. Department of Medicine at School of Medicine, University of Alabama, 1670 University Boulevard, Birmingham 35233, AL, USA. Division of Epidemiology at School of Public Health, University of Alabama, 1665 University Boulevard, Birmingham 35233, AL, USA. Department of Orthopedic Surgery, Mayo Clinic College of Medicine, 200 1st St SW, Rochester 55905, MN, USA. Takeda Pharmaceuticals International, Inc., One Takeda Parkway, Deerfield 60015, IL, USA. University of Alabama, Faculty Office Tower 805B, 510 20th Street S, Birmingham 35294, AL, USA.
منابع مشابه
Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
INTRODUCTION To assess the comparative effectiveness of febuxostat and allopurinol in reducing serum urate (sUA) levels in a real-world U.S. managed care setting. METHODS This retrospective study utilized 2009 to 2012 medical and pharmacy claims and laboratory data from a large U.S. commercial and Medicare Advantage health plan. Study patients had at least one medical claim with a diagnosis o...
متن کاملCost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective.
BACKGROUND Gout is a chronic inflammatory condition associated with poor urate metabolism. Xanthine oxidase inhibitors such as allopurinol and febuxostat are recommended to reduce uric acid levels and to prevent gout attacks in adult patients. Under budget-driven constraints, health care payers are faced with the broader challenge of assessing the economic value of these agents for formulary pl...
متن کاملTreatment failure gout.
Treatment options for gout are well established and reasonably effective. They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effective urate-lowering therapy, there remains a subset of patients with gout who, despite aggr...
متن کاملComparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis
The prevalence of hyperuricemia and gout has been increasing, but the comparative effectiveness and safety of different treatments remain uncertain. We aimed to compare the effectiveness and safety of different treatments for hyperuricemia using network meta-analysis methodology. We systematically reviewed fifteen randomized controlled trials (involving 7,246 patients through January 2016) that...
متن کاملCan racial disparities in optimal gout treatment be reduced? evidence from a randomized trial
There is a disproportionate burden of gout in African-Americans in the U.S. due to a higher disease prevalence and lower likelihood of receiving urate-lowering therapy (ULT), compared to Caucasians. There is an absence of strong data as to whether the response to ULT differs by race/ethnicity. BMC Musculoskeletal Disorders recently published a secondary analyses of the CONFIRMS trial, a large r...
متن کامل